Posted By John Morris On 12 Dec 2025 Comments (3)
Specialists often choose brand-name specialty drugs over cheaper biosimilars due to clinical uncertainty, administrative burdens, hidden pricing practices, and patient pressure-despite evidence showing alternatives work just as well.
READ MORE